273 related articles for article (PubMed ID: 20708968)
21. Intrinsic toxicity of hemoglobin: how to counteract it.
Simoni J; Simoni G; Moeller JF
Artif Organs; 2009 Feb; 33(2):100-9. PubMed ID: 19178453
[TBL] [Abstract][Full Text] [Related]
22. Civilian uses of hemoglobin-based oxygen carriers.
Greenburg AG; Kim HW
Artif Organs; 2004 Sep; 28(9):795-9. PubMed ID: 15320942
[TBL] [Abstract][Full Text] [Related]
23. How to evaluate blood substitutes for endothelial cell toxicity.
Gaucher C; Menu P
Antioxid Redox Signal; 2008 Jul; 10(7):1153-62. PubMed ID: 18331203
[TBL] [Abstract][Full Text] [Related]
24. Review of hemoglobin-vesicles as artificial oxygen carriers.
Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
[TBL] [Abstract][Full Text] [Related]
25. Clinical contextualization and the assessment of adverse events in HBOC trials.
Greenburg AG; Pitman A; Pearce B; Kim HW
Artif Cells Blood Substit Immobil Biotechnol; 2008; 36(6):477-86. PubMed ID: 19039687
[TBL] [Abstract][Full Text] [Related]
26. Novel hemoglobin particles--promising new-generation hemoglobin-based oxygen carriers.
Bäumler H; Xiong Y; Liu ZZ; Patzak A; Georgieva R
Artif Organs; 2014 Aug; 38(8):708-14. PubMed ID: 24962099
[TBL] [Abstract][Full Text] [Related]
27. Resuscitation with a novel hemoglobin-based oxygen carrier in a Swine model of uncontrolled perioperative hemorrhage.
Malhotra AK; Kelly ME; Miller PR; Hartman JC; Fabian TC; Proctor KG
J Trauma; 2003 May; 54(5):915-24. PubMed ID: 12777904
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
Taguchi K; Maruyama T; Otagiri M
Drug Metab Rev; 2011 Aug; 43(3):362-73. PubMed ID: 21428698
[TBL] [Abstract][Full Text] [Related]
29. Oxidative stress resulting from hemolysis and formation of catalytically active hemoglobin: protective strategies.
Ziouzenkova O; Asatryan L; Sevanian A
Int J Clin Pharmacol Ther; 1999 Mar; 37(3):125-32. PubMed ID: 10190760
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin-based oxygen carrier enhanced tumor oxygenation: a novel strategy for cancer therapy.
Gundersen SI; Palmer AF
Biotechnol Prog; 2008; 24(6):1353-64. PubMed ID: 19194950
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and mechanisms of plasma removal of hemoglobin-based oxygen carriers.
Estep TN
Artif Cells Nanomed Biotechnol; 2015 Jun; 43(3):203-15. PubMed ID: 26024447
[TBL] [Abstract][Full Text] [Related]
32. High O2 affinity hemoglobin-based oxygen carriers synthesized via polymerization of hemoglobin with ring-opened 2-chloroethyl-beta-D-fructopyranoside and 1-o-octyl-beta-D-glucopyranoside.
Dimino ML; Palmer AF
Biotechnol Bioeng; 2007 Jun; 97(3):462-72. PubMed ID: 17115452
[TBL] [Abstract][Full Text] [Related]
33. Arterial oxygenation and oxygen delivery after hemoglobin-based oxygen carrier infusion in canine hypovolemic shock: a dose-response study.
Driessen B; Jahr JS; Lurie F; Golkaryeh MS; Gunther RA
Crit Care Med; 2003 Jun; 31(6):1771-9. PubMed ID: 12794419
[TBL] [Abstract][Full Text] [Related]
34. Preclinical biology of recombinant human hemoglobin, rHb1.1.
Zuckerman SH; Doyle MP; Gorczynski R; Rosenthal GJ
Artif Cells Blood Substit Immobil Biotechnol; 1998 May; 26(3):231-57. PubMed ID: 9635118
[TBL] [Abstract][Full Text] [Related]
35. Crosslinked, polymerized, and PEG-conjugated hemoglobin-based oxygen carriers: clinical safety and efficacy of recent and current products.
Jahr JS; Akha AS; Holtby RJ
Curr Drug Discov Technol; 2012 Sep; 9(3):158-65. PubMed ID: 21745179
[TBL] [Abstract][Full Text] [Related]
36. Interpretation of hemolysis tests following administration of a second-generation hemoglobin-based oxygen carrier.
Drieghe S; Stove V; Decruyenaere J; Delanghe J
Acta Clin Belg; 2013; 68(4):282-6. PubMed ID: 24455798
[TBL] [Abstract][Full Text] [Related]
37. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?
Alayash AI
Nat Biotechnol; 1999 Jun; 17(6):545-9. PubMed ID: 10385317
[TBL] [Abstract][Full Text] [Related]
38. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?
Napolitano LM
Crit Care Clin; 2009 Apr; 25(2):279-301, Table of Contents. PubMed ID: 19341909
[TBL] [Abstract][Full Text] [Related]
39. Allosteric effects on oxidative and nitrosative reactions of cell-free hemoglobins.
Bonaventura C; Henkens R; Alayash AI; Crumbliss AL
IUBMB Life; 2007; 59(8-9):498-505. PubMed ID: 17701544
[TBL] [Abstract][Full Text] [Related]
40. Hemoglobin solutions.
Creteur J; Vincent JL
Crit Care Med; 2003 Dec; 31(12 Suppl):S698-707. PubMed ID: 14724468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
